Homes and Property | Home Page

AstraZeneca's drug approved

13 April 2012

ASTRAZENECA shares should move much higher today after US regulators approved the launch of Iressa, a drug for lung cancer sufferers. The drug has been linked to deaths in Japan and there were fears it would be blocked in the US. The medicine will help offset loss of sales from ulcer treatment Losec, which has lost patent protection.

Create a FREE account to continue reading

eros

Registration is a free and easy way to support our journalism.

Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.

Your email address

Must be at least 6 characters, include an upper and lower case character and a number

You must be at least 18 years old to create an account

* Required fields

Already have an account? SIGN IN

By clicking Create Account you confirm that your data has been entered correctly and you have read and agree to our Terms of use , Cookie policy and Privacy policy .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in